[GLP-1 and the control of insulin secretion].
Thorens
B
B
Institut de Pharmacologie, Lausanne, Suisse.
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology; D005934:Glucagon / Q000737:chemistry / Q000502:physiology*; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D010446:Peptide Fragments / Q000737:chemistry / Q000502:physiology*; D011498:Protein Precursors / Q000737:chemistry / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D013329:Structure-Activity Relationship
D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D052216:Glucagon-Like Peptide 1; D005934:Glucagon
Le GLP-1 et le contrôle de la sécrétion d'insuline.